204 related articles for article (PubMed ID: 35086093)
1. The Bacteriology of Skin Lesions in Patients with Hidradenitis Suppurativa Is Associated with Previous Antibiotic Treatment in the Community Setting: A Referral Center Experience.
Barmatz S; Fisch-Gilad S; Hackett A; Barak Levitt J; Dalal A; Taieb Y; Kremer N; Levi A; Pavlovsky L; Hodak E; Yahav D; Sherman S
Dermatology; 2022; 238(4):772-784. PubMed ID: 35086093
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
3. Rates of antibiotic resistance/sensitivity in bacterial cultures of hidradenitis suppurativa patients.
Bettoli V; Manfredini M; Massoli L; Carillo C; Barozzi A; Amendolagine G; Ruina G; Musmeci D; Libanore M; Curtolo A; Mantovani L; Contini C; Pellacani G; Corazza M
J Eur Acad Dermatol Venereol; 2019 May; 33(5):930-936. PubMed ID: 30394587
[TBL] [Abstract][Full Text] [Related]
4. Biofilm production and antibiotic susceptibility of Staphylococcus epidermidis strains from Hidradenitis Suppurativa lesions.
Ardon CB; Prens EP; Fuursted K; Ejaz RN; Shailes J; Jenssen H; Jemec GBE
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):170-177. PubMed ID: 30022542
[TBL] [Abstract][Full Text] [Related]
5. Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment.
Sartorius K; Killasli H; Oprica C; Sullivan A; Lapins J
Br J Dermatol; 2012 Apr; 166(4):879-83. PubMed ID: 22098253
[TBL] [Abstract][Full Text] [Related]
6. The bacteriology of hidradenitis suppurativa: a systematic review.
Ring HC; Riis Mikkelsen P; Miller IM; Jenssen H; Fuursted K; Saunte DM; Jemec GB
Exp Dermatol; 2015 Oct; 24(10):727-31. PubMed ID: 26119625
[TBL] [Abstract][Full Text] [Related]
7. Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa.
Fischer AH; Haskin A; Okoye GA
J Am Acad Dermatol; 2017 Feb; 76(2):309-313.e2. PubMed ID: 27742173
[TBL] [Abstract][Full Text] [Related]
8. The Microbiology of Hidradenitis Suppurativa.
Ring HC; Emtestam L
Dermatol Clin; 2016 Jan; 34(1):29-35. PubMed ID: 26617355
[TBL] [Abstract][Full Text] [Related]
9. Boils at Frictional Locations in a Patient with Hidradenitis Suppurativa.
Boer J; Mihajlovic D
Acta Dermatovenerol Croat; 2016 Dec; 24(4):303-304. PubMed ID: 28128084
[TBL] [Abstract][Full Text] [Related]
10. Microbial Profile and Antimicrobial Susceptibility of Bacteria Found in Inflammatory Hidradenitis Suppurativa Lesions.
Hessam S; Sand M; Georgas D; Anders A; Bechara FG
Skin Pharmacol Physiol; 2016; 29(3):161-7. PubMed ID: 27351708
[TBL] [Abstract][Full Text] [Related]
11. Recalcitrant Hidradenitis Suppurativa: An Investigation of Demographics, Surgical Management, Bacterial Isolates, Pharmacologic Intervention, and Patient-reported Health Outcomes.
Thomas C; Rodby KA; Thomas J; Shay E; Antony AK
Am Surg; 2016 Apr; 82(4):362-8. PubMed ID: 27097631
[TBL] [Abstract][Full Text] [Related]
12. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
[TBL] [Abstract][Full Text] [Related]
13. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of anti-inflammatory effects of rifampicin in an ex vivo culture system of hidradenitis suppurativa.
Haferland I; Wallenwein CM; Ickelsheimer T; Diehl S; Wacker MG; Schiffmann S; Buerger C; Kaufmann R; Koenig A; Pinter A
Exp Dermatol; 2022 Jul; 31(7):1005-1013. PubMed ID: 35048417
[TBL] [Abstract][Full Text] [Related]
15. Hidradenitis Suppurativa: Advances in Diagnosis and Treatment.
Saunte DML; Jemec GBE
JAMA; 2017 Nov; 318(20):2019-2032. PubMed ID: 29183082
[TBL] [Abstract][Full Text] [Related]
16. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.
Mendonça CO; Griffiths CE
Br J Dermatol; 2006 May; 154(5):977-8. PubMed ID: 16634904
[TBL] [Abstract][Full Text] [Related]
17. Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system.
Scheinfeld N
Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617596
[TBL] [Abstract][Full Text] [Related]
18. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery.
Lapins J; Jarstrand C; Emtestam L
Br J Dermatol; 1999 Jan; 140(1):90-5. PubMed ID: 10215774
[TBL] [Abstract][Full Text] [Related]
19. Hidradenitis suppurativa: bacteriological study in surgical treatment.
Gierek M; Ochała-Gierek G; Kitala D; Łabuś W; Bergler-Czop B
Postepy Dermatol Alergol; 2022 Dec; 39(6):1101-1105. PubMed ID: 36686013
[TBL] [Abstract][Full Text] [Related]
20. Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.
Dessinioti C; Zisimou C; Tzanetakou V; Stratigos A; Antoniou C
Clin Exp Dermatol; 2016 Dec; 41(8):852-857. PubMed ID: 27753139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
